X0304 4 2012-01-03 0 0001048477 BIOMARIN PHARMACEUTICAL INC BMRN 0001197355 FUCHS HENRY J C/O BIOMARIN PHARMACEUTICAL INC. 105 DIGITAL DRIVE NOVATO CA 94949 0 1 0 0 EVP, Chief Medical Officer Common Stock 2011-10-31 2011-10-31 5 A 0 156 13.226 A 36611 D Common Stock 2012-01-03 2012-01-03 4 M 0 2500 11.05 A 39111 D Common Stock 2012-01-03 2012-01-03 4 S 0 2500 34.7532 D 36611 D Stock Option (right to buy) 11.05 2012-01-03 2012-01-03 4 M 0 2500 0 D 2009-09-02 2019-03-01 Common Stock 2500 286000 D The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the isuer's Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of April 29, 2011 to October 31, 2011. Transaction made pursuant to a Rule 10b5-1 Trading plan executed on April 1, 2011. The range of sales prices received was $34.47 to $35.18. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price. Original option grant vests 6/48ths on September 2, 2009 and 1/48th on the 2nd of each month thereafter. /s/ Laura Randall Woodhead, Attorney-in-Fact 2012-01-04